SimonMed Imaging has introduced two new AI-assisted screening services — Mammogram+ and Mammogram+ Heart — designed to improve early detection of breast cancer and cardiovascular disease.

The Scottsdale, Arizona-based imaging provider said the offerings combine AI with subspecialty radiologist review. Mammogram+ is an upgraded version of the company’s previous Personalized Breast Cancer Detection (PBCD) program, aimed at identifying malignancies sooner while also factoring in breast density and lifetime cancer risk. Mammogram+ Heart adds an AI-based analysis of breast arterial calcification (BAC), a biomarker increasingly associated with cardiovascular risk in women.

SimonMed operates roughly 170 outpatient imaging centers across 11 states and is known for integrating AI technologies into clinical diagnostics.
Both services are available as add-ons to standard mammograms at SimonMed sites across the U.S., priced at $50 for Mammogram+ and $90 for Mammogram+ Heart. No physician referral is required.

“Mammogram+ and Mammogram+ Heart combine advanced AI to detect breast cancer earlier and identify early signs of heart disease; offering valuable insight into both breast and heart health through a single exam,” said Dr. John Simon, CEO and founder of SimonMed Imaging.

The BAC analysis in Mammogram+ Heart draws on emerging research linking calcifications in breast arteries to a higher likelihood of cardiovascular events. The feature aims to support earlier intervention, though it is not a diagnostic tool for heart disease.

Artificial Intelligence Homepage